Binary MoS2 nanostructures as nanocarriers for amplification in multiplexed electrochemical immunosensing: simultaneous determination of B cell activation factor and proliferation-induced signal immunity-related cytokines

A dual immunosensor is reported for the simultaneous determination of two important immunity-related cytokines: BAFF (B cell activation factor) and APRIL (a proliferation-induced signal). Sandwich-type immunoassays with specifc antibodies (cAbs) and a strategy for signal amplifcation based on labell...

Descripción completa

Detalles Bibliográficos
Autores: Arévalo Pérez, Beatriz, Blázquez García, Marina, Valverde De La Fuente, Alejandro, Serafín González-Carrato, Verónica, Montero Calle, Ana, Solís Fernández, Guillermo, Barderas Manchado, Rodrigo, Campuzano Ruiz, Susana, Yáñez-Sedeño Orive, Paloma, Pingarron, José M.
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/71579
Acceso en línea:https://hdl.handle.net/20.500.14352/71579
Access Level:acceso abierto
Palabra clave:543
Dual immunoplatform
BAFF
APRIL
MoS2/MWCNTs
Amperometry
Serum
SLE
CRC
Química analítica (Química)
2301 Química Analítica
Descripción
Sumario:A dual immunosensor is reported for the simultaneous determination of two important immunity-related cytokines: BAFF (B cell activation factor) and APRIL (a proliferation-induced signal). Sandwich-type immunoassays with specifc antibodies (cAbs) and a strategy for signal amplifcation based on labelling the detection antibodies (dAbs) with binary MoS2/ MWCNTs nanostructures and using horseradish peroxidase (HRP) were implemented. Amperometric detection was carried out at screen-printed dual carbon electrodes (SPdCEs) through the hydroquinone HQ/H2O2 system. The developed dual immunosensor provided limit of detection (LOD) of 0.08 and 0.06 ng mL−1 for BAFF and APRIL, respectively, and proved to be useful for the determination of both cytokines in cancer cell lysates and serum samples from patients diagnosed with autoimmune diseases and cancer. The obtained results agreed with those found using ELISA methodologies.